Clinical Trial

Hypno-Breastfeeding Education and Postpartum Outcomes

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 14, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial aims to examine the effects of hypno-breastfeeding-based education on postpartum anxiety, self-compassion, breastfeeding motivation, and breastfeeding self-efficacy among mothers in the early postpartum period. The postpartum period is a critical phase characterized by significant physical and psychological changes. Primiparous mothers, in particular, may experience anxiety, lack of confidence, and reduced motivation for breastfeeding, which may negatively affect breastfeeding success and mother-infant bonding. The study will be conducted with 102 primiparous mothers aged 18-40 years within the first 72 hours postpartum. Participants will be randomly assigned to intervention and control groups. The intervention group will receive hypno-breastfeeding-based education, while the control group will receive routine care. The educational program includes principles of hypnosis, breastfeeding knowledge, anxiety management, self-efficacy enhancement, and self-awareness techniques, supported by guided relaxation, breathing exercises, and positive suggestion methods. Data will be collected using validated scales, including the Postpartum-Specific Anxiety Scale, Self-Compassion Scale, Breastfeeding Motivation Scale, and Breastfeeding Self-Efficacy Scale. Appropriate statistical analyses will be performed. The findings are expected to contribute to the development of psychoeducational nursing interventions, reduce postpartum anxiety, improve breastfeeding outcomes, and strengthen maternal adaptation.
Trial Details
NCT Number NCT07528001
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Postpartum Anxiety
Enrollment 102 participants
Start Date 2026-04-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-14